blood loss
Conditions
Interventions
Tranexamic Acid and Ethamsylate Group
Sponsors
Sayed Galal
Shoubra General Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1-Pregnant females admitted for elective Cesarean Section 2-Gestational age (38 to 41 weeks) 3- Age of the participants: 20y to 40 years 4- Body Mass Index (18.5 - 29.9) 5-Singleton living fetus. 6-No medical disorders.
Exclusion criteria
Exclusion criteria: 1 - Medical and surgical disorders as thyroid dysfunction, which was excluded by routine thyroid function test (free T3, free T4, and thyroid-stimulating hormone(TSH), all of them should be within normal limits). 2 -Bleeding tendency, was excluded by platelet count, coagulation time, bleeding time, prothrombin time, partial thromboplastin time, and thrombin time (all should be within normal). 3 -Acute and chronic liver or kidney diseases; blood disorders, such as anemia. 4 -Allergy to Tranexamic acid or any drug used. 5 -Risk factors for PPH, such as polyhydramnios, fetal macrosomia, antepartum hemorrhage. 6 - Abnormal placentae such as placenta previa and placental abruption. 7 -Pregnancy complications such as severe pre-eclampsia, Gestational HTN, Gestational DM, and multi Fetal pregnancies, those requiring blood transfusion. 8 - Patients who refused spinal anesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome of the study will be measured in terms of assessment of Hemoglobin level and Hematocrit level pre and post operatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome of the study will be measured in terms of assessment of Hemoglobin level and Hematocrit level post operatively. | — |
Countries
Egypt
Contacts
Public ContactElsayed ElDesouky
AlAzhar Faculty of medicine
Outcome results
None listed